Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO

Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO

Source: 
Endpoints
snippet: 

A coronavirus fear-induced bloodbath on the Nasdaq has not stopped Passage Bio from making a public debut — and an exuberant one.